[1] Pang H, Zhang L, Han S, et al. A nationwide population-based survey on the prevalence and risk factors of symptomatic pelvic organ prolapse in adult women in China-a pelvic organ prolapse quantification system-based study. BJOG, 2021; 128, 1313−23. doi:  10.1111/1471-0528.16675
[2] Lang JH. Urogynecology and reconstructive pelvic surgery: past, present and future 2. Chin J Obstet Gynecol, 2005; 40, 145−7. (In Chinese
[3] Koelling S, Clauditz TS, Kaste M, et al. Cartilage oligomeric matrix protein is involved in human limb development and in the pathogenesis of osteoarthritis. Arthritis Res Ther, 2006; 8, R56. doi:  10.1186/ar1922
[4] Jiang Y, Muschel RJ. Regulation of matrix metalloproteinase-9 (MMP-9) by translational efficiency in murine prostate carcinoma cells. Cancer Res, 2002; 62, 1910−4.
[5] Posey KL, Coustry F, Hecht JT. Cartilage oligomeric matrix protein: COMPopathies and beyond. Matrix Biol, 2018; 71-72, 161-73.
[6] Magdaleno F, Arriazu E, De Galarreta MR, et al. Cartilage oligomeric matrix protein participates in the pathogenesis of liver fibrosis. J Hepatol, 2016; 65, 963−71. doi:  10.1016/j.jhep.2016.06.003
[7] Saputra AND, Rizal DM, Ayuandari S, et al. The difference in collagen type-1 expression in women with and without pelvic organ prolapse: a systematic review and meta-analysis. Int Urogynecol J, 2022; 33, 1803−12. doi:  10.1007/s00192-022-05229-y
[8] Li L, Zhao GY, Wu J, et al. Interactions between genetic variants and environmental risk factors are associated with the severity of pelvic organ prolapse. Menopause, 2023; 30, 621−8. doi:  10.1097/GME.0000000000002182
[9] Bałkowiec M, Maksym RB, Wlodarski PK. The bimodal role of matrix metalloproteinases and their inhibitors in etiology and pathogenesis of endometriosis (Review). Mol Med Rep, 2018; 18, 3123−36.
[10] Wu JM, Visco AG, Grass EA, et al. Matrix metalloproteinase-9 genetic polymorphisms and the risk for advanced pelvic organ prolapse. Obstet Gynecol, 2012; 120, 587−93. doi:  10.1097/AOG.0b013e318262234b